News & Perspective

Jul 23, 2015

Jul 23, 2015

News Scan for Jul 23, 2015

MERS in Saudi Arabia
H5N2 vaccine in chickens
Experimental Marburg drug
Klebsiella in retail meat
Epidemic threat poll
EV-D68 rapid test

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Mar 31, 2009

Mar 31, 2009

Experts update businesses on antiviral stockpiling

(CIDRAP News) – Antiviral resistance and the global economic downturn might present new obstacles for corporate antiviral stockpiling, but two medical experts today said the medications are still quick, reliable tools that can help preserve business continuity in an influenza pandemic.

Jul 18, 2006

Jul 18, 2006

Novartis to build US cell-based flu vaccine plant

(CIDRAP News) – Novartis, the Swiss-based drug manufacturer, today announced plans to build what it says will be the first US plant to make cell-culture-based influenza vaccines.

The facility will be built in Holly Springs, N.C., at a total cost of about $600 million, the company said in a news release. It will be able to produce about 50 million doses of seasonal trivalent (three-strain) flu vaccine annually.

Nov 08, 2005

Nov 08, 2005

US calls for expert panel to plan pandemic response

(CIDRAP News) – The United States proposed today that a small group of experts be appointed immediately to plan a fast response in case an influenza pandemic erupts, as an international conference on avian and pandemic flu continued in Geneva.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»